1. Home
  2. DOMH vs POAI Comparison

DOMH vs POAI Comparison

Compare DOMH & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMH
  • POAI
  • Stock Information
  • Founded
  • DOMH 1967
  • POAI 2002
  • Country
  • DOMH United States
  • POAI United States
  • Employees
  • DOMH N/A
  • POAI 35
  • Industry
  • DOMH Biotechnology: Pharmaceutical Preparations
  • POAI Industrial Specialties
  • Sector
  • DOMH Health Care
  • POAI Health Care
  • Exchange
  • DOMH Nasdaq
  • POAI Nasdaq
  • Market Cap
  • DOMH 8.8M
  • POAI 9.7M
  • IPO Year
  • DOMH N/A
  • POAI N/A
  • Fundamental
  • Price
  • DOMH $3.02
  • POAI $1.46
  • Analyst Decision
  • DOMH
  • POAI Hold
  • Analyst Count
  • DOMH 0
  • POAI 1
  • Target Price
  • DOMH N/A
  • POAI N/A
  • AVG Volume (30 Days)
  • DOMH 421.3K
  • POAI 2.9M
  • Earning Date
  • DOMH 03-31-2025
  • POAI 03-27-2025
  • Dividend Yield
  • DOMH N/A
  • POAI N/A
  • EPS Growth
  • DOMH N/A
  • POAI N/A
  • EPS
  • DOMH N/A
  • POAI N/A
  • Revenue
  • DOMH $12,589,000.00
  • POAI $1,484,223.00
  • Revenue This Year
  • DOMH N/A
  • POAI N/A
  • Revenue Next Year
  • DOMH N/A
  • POAI $569.48
  • P/E Ratio
  • DOMH N/A
  • POAI N/A
  • Revenue Growth
  • DOMH 1117.50
  • POAI N/A
  • 52 Week Low
  • DOMH $0.83
  • POAI $0.55
  • 52 Week High
  • DOMH $4.35
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • DOMH 65.22
  • POAI 59.80
  • Support Level
  • DOMH $2.86
  • POAI $1.36
  • Resistance Level
  • DOMH $4.35
  • POAI $1.58
  • Average True Range (ATR)
  • DOMH 0.52
  • POAI 0.21
  • MACD
  • DOMH 0.14
  • POAI -0.01
  • Stochastic Oscillator
  • DOMH 53.19
  • POAI 30.58

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: